New Delhi: Sputnik’s single-dose COVID-19 vaccine, Sputnik Light, has received the approval of the Drugs Controller General of India (DCGI) to conduct phase III bridging trials on the Indian population.
The Subject Expert Committee (SEC) of the DCGI recommended the phase III bridging trials for Sputnik Light, India Today reported.
Earlier in July, the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had refused to grant emergency use authorisation to Sputnik Light noting that it was the same as component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population was already generated in a trial.
Dr Reddy’s Laboratories had partnered with the Russian Direct Investment Fund (RDIF) last year to conduct the phase III trials of Sputnik V vaccine in India. Dr Reddy’s was asked by the SEC to submit the safety, immunogenicity and efficacy data from the phase III clinical trial of Sputnik-Light in Russia for the market authorisation of the single-shot vaccine in India.
About Sputnik Light
Bhubaneswar: Biju Janata Dal (BJD) on Wednesday moved the Election Commission of India (ECI) accusing…
New Delhi: Is Sobhita Dhulipala dating Samantha Ruth Prabhu’s ex-husband Naga Chaitanya? Sobhita, who has starred…
Bhubaneswar: Announcing yet another replacement of nominee for the upcoming elections in Odisha, Congress changed…
Bhubaneswar: The Indian senior men’s football team will prepare for next month’s crucial World Cup qualifiers…
Bhubaneswar: Biju Janata Dal (BJD) president and Chief Minister Naveen Patnaik, who kicked off party’s…
Jaipur: Congress is desperate to unseat Bharatiya Janata Party (BJP) from the Centre. But some…
Bhubaneswar: A total of 26 fire alerts were received in Similipal Tiger Reserve (STR) in…
Jaipur: A BJP Minority Morcha leader in Rajasthan has been expelled from the party for ‘tarnishing’…